Kalkine has a fully transformed New Avatar.
Appen Limited
APX Details
1HFY21 Results: Appen Limited (ASX: APX) offers data services and solutions for artificial intelligence (AI) and machine learning. APX operates relevance and speech & image segments. It serves sectors such as automotive, retail, technology, healthcare, financial services, and government agencies.
Key Financial Highlights; (Analysis by Kalkine Group)
Key Risks: The company faces the risk of technological changes, reliance and retention on competitive and skilled staff, peer competition, and COVID-19 uncertainty.
Outlook:
Valuation Methodology: P/E Multiple Based Relative Valuation (Illustrative)
Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: The stock of APX gave a negative return of ~2.00% in the past three months and a negative return of ~29.38% in the past six months. The stock is currently trading lower than the 52-weeks’ average price level band of $8.360 - $28.260. The stock has been valued using the P/E-multiple based illustrative relative valuation method and arrived at a target price of low double-digit upside (in % terms). The company might trade at a slight discount than its peers’ median P/E multiple, considering its impacted 1HFY21 financials, COVID-19 disruptions, and narrowed down guidance of underlying EBITDA. For this purpose of valuation, few peers like TechnologyOne Limited (ASX: TNE), Data#3 Limited (ASX: DTL), Class Limited (ASX: CL1) have been considered. Considering the current trading levels, new customer wins in 1HFY21, expected growth of New Markets division and Global Services division in FY21, valuation, and associated key business risks, we give a ‘Speculative Buy’ rating on the stock at the current market price of $9.560, as of 10 December 2021, 10:30 AM (GMT+10), Sydney, Eastern Australia.
APX Daily Technical Chart, Data Source: REFINITIV
Integrated Research Limited
IRI Details
Issue of Performance Shares & Options: Integrated Research Limited (ASX: IRI) develops and markets systems and applications management computer software for unified communication (UC) networks & payment networks, and business computing. It serves the US, Europe, and the Asia Pacific. On 2 December 2021, IRI issued ~1.03 million performance shares to staff under a long-term incentive plan.
Trading Update & Management’s Address at the AGM:
Key Financial from 1HFY20-2HFY21; (Analysis by Kalkine Group)
Key Risks: The company faces the risk of technological changes, forex headwinds, structural changes in the industry. It faces the COVID-19 impact of deal deferrals and prudent capital spend by customers.
Outlook:
Valuation Methodology: P/E Multiple Based Relative Valuation (Illustrative)
Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: The stock of IRI gave a negative return of ~34.94% in the past three months and a negative return of ~43.19% in the past six months. The stock is currently trading lower than the 52-weeks’ average price level band of $1.135 - $3.350. The stock has been valued using the P/E multiple-based illustrative relative valuation method and arrived at a target price of low double-digit upside (in % terms). The company might trade at a slight discount than its peers’ average P/E multiple, considering its decline in FY21 results, a slight uptick in debt-to-equity ratio, the risk of structural changes in the industry, and timing of SaaS revenue realisation. For this purpose of valuation, few peers like Over the Wire Holdings Limited (ASX: OTW), Iress Limited (ASX: IRE), Nuix Limited (ASX: NXL), and others have been considered. Considering the current trading levels, diversification towards an evolving business model & SaaS subscription revenue, continuing product innovation and enhancements in FY21, new customers in FY22, positive cash flows, valuation, and associated key business risks, we give a ‘Speculative Buy’ rating on the stock at the closing market price of $1.210, down by ~5.099%, as of 10 December 2021.
IRI Daily Technical Chart, Data Source: REFINITIV
Tesserent Limited
TNT Details
Entered Acquisition Agreements: Tesserent Limited (ASX: TNT) offers cloud, managed services, and cyber security consulting services to firms, education providers, and government customers in Australia and overseas. On 7 December 2021, TNT declared the acquisition of Claricent Pty Limited (Claricent) and Pearson Corporation Pty Limited (Pearson) by signing two distinct share purchase agreements with the corresponding vendors.
Trading Update as on the Date of AGM Held (19 November 2021):
Liquidity & Debt Position; (Analysis by Kalkine Group)
Key Risks: The company faces cybersecurity risks, regulatory delays/changes, industry competition, and realisation of synergies from multiple acquisitions.
Outlook:
Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)
Source: Analysis by Kalkine Group
*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation: The stock of TNT gave a negative return of ~22.72% in the past three months and a negative return of ~22.72% in the past six months. The stock is currently trading towards its 52-weeks’ average price level band of $0.150 - $0.440. The stock has been valued using the Enterprise Value to Sales based illustrative relative valuation method and arrived at a target price of low double-digit upside (in % terms). The company might trade at a slight discount than its peers’ median EV/Sales multiple, considering its negative net margin, negative ROE, the risk of synergies from multiple recent acquisitions, and forex rate changes. For this purpose of valuation, few peers like Integrated Research Limited (ASX: IRI), Adacel Technologies Limited (ASX: ADA), Reckon Limited (ASX: RKN), and others have been considered. Considering the current trading levels, improved cash position as of 15 November 2021, growth in FY21 revenue, expected earnings, cash flows, and EPS accretion from the two acquisitions, valuation, and associated key business risks, we give a ‘Speculative Buy’ rating on the stock at the current market price of $0.170, as of 10 December 2021, 11:22 AM (GMT+10), Sydney, Eastern Australia.
TNT Daily Technical Chart, Data Source: REFINITIV
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.